Responses on Alliança–Meddi deal review in Brazil show mixed concerns
Concerns over Alliança Saúde’s proposed acquisition of Grupo Meddi are concentrated but not dominant, according to public responses gathered by Brazil’s competition authority. While some competitors warn of regional market concentration...To view the full article, register now.
Already a subscriber? Click here to view full article